A Randomized Double-blind Placebo-controlled Combined Single Ascending Dose and Multiple Ascending Dose Study to Assess Safety Tolerability Immunogenicity Pharmacodynamic Response and Pharmacokinetics of Intravenous Infusions of BAN2401 in Subjects
M
Martin Farlow, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
The purpose of this research is to find out if this study drug is safe and well-tolerated in people with Alzheimer
Description
The purpose of this research is to find out if this study drug is safe and well-tolerated in people with Alzheimer
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Alzheimer's Disease
-
Age: Between 50 Years - 100 Years
-
Gender: All
Updated on
30 Apr 2024.
Study ID: 1105005336 (1009-03)
